3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects
- 31 August 2010
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 31 (8), 1284-1303
- https://doi.org/10.1016/j.neurobiolaging.2010.05.003
Abstract
No abstract availableThis publication has 87 references indexed in Scilit:
- Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normalNeurobiology of Aging, 2010
- Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal ElderlyBiological Psychiatry, 2010
- APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal agingAnnals of Neurology, 2010
- Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound BArchives of Neurology, 2009
- Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer DiseaseArchives of Neurology, 2009
- Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfieldsHippocampus, 2009
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjectsAnnals of Neurology, 2009
- Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderlyAnnals of Neurology, 2009
- Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controlsHuman Brain Mapping, 2009
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methodsJournal of Magnetic Resonance Imaging, 2008